Stock Market News

FDA grants orphan drug status to Sanofi's Rilzabrutinib

Jun 3, 2025 - 07:10
 0
FDA grants orphan drug status to Sanofi's Rilzabrutinib
Read More

Tags:

Previous Article

SAMT: Highly Sophisticated Active Strategy With Unconvincing Returns

Next Article

Norwegian crypto platform spikes 138% on Bitcoin treasury plan

Related Posts

U.S. stocks higher at close of trade; Dow Jones Industr...

Jun 3, 2025  0

Commerzbank CEO and workers rally to fend off UniCredit as investors meet

Commerzbank CEO and workers rally to fend off UniCredit...

May 15, 2025  0

India stocks lower at close of trade; Nifty 50 down 0.17%

India stocks lower at close of trade; Nifty 50 down 0.17%

May 16, 2025  0